Adjusted NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles and lease termination fees (?non cash adjustments?). Adjusted NOI is oftentimes referred to as ?cash NOI.? The Company uses adjusted NOI to make decisions about resource allocations, and to assess and compare property level performance. The Company believes that net income (loss) is the most directly comparable U.S. GAAP measure to adjusted NOI. Adjusted NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect various excluded items. Further, the Company?s definition of Adjusted NOI may not be comparable to the definition used by other REITs or real estate companies, as they may use different methodologies for calculating Adjusted NOI.

No definition available.

Segment Disclosures - Summary Information for the Reportable Segments (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended								12 Months Ended
	Jul. 31, 2022	Jan. 31, 2022	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			$ 524,468	$ 520,406	$ 517,932	$ 498,372	$ 483,205	$ 481,465	$ 476,238	$ 455,276	$ 2,061,178	$ 1,896,184	$ 1,644,875
Government grant income											6,765	1,412	16,198
Less: Interest income											(23,300)	(37,773)	(16,553)
Healthpeak’s share of unconsolidated joint venture total revenues											86,805	83,377	112,635
Healthpeak’s share of unconsolidated joint venture government grant income											878	1,749	1,279
Noncontrolling interests’ share of consolidated joint venture total revenues											(35,985)	(35,655)	(34,836)
Operating expenses											(862,991)	(773,279)	(782,541)
Healthpeak’s share of unconsolidated joint venture operating expenses											(61,693)	(61,515)	(87,170)
Noncontrolling interests’ share of consolidated joint venture operating expenses											10,404	10,158	10,354
Adjustments to NOI											(75,798)	(54,513)	71,828
Adjusted NOI											1,106,263	1,030,145	936,069
Plus: Adjustments to NOI											75,798	54,513	(71,828)
Interest income											23,300	37,773	16,553
Interest expense											(172,944)	(157,980)	(218,336)
Depreciation and amortization											(710,569)	(684,286)	(553,949)
General and administrative											(131,033)	(98,303)	(93,237)
Transaction costs											(4,853)	(1,841)	(18,342)
Impairments and loan loss reserves, net											(7,004)	(23,160)	(42,909)
Gain (loss) on sales of real estate, net											9,078	190,590	90,350
Gain (loss) on debt extinguishments											0	(225,824)	(42,912)
Other income (expense), net											326,268	6,266	234,684
Less: Government grant income											(6,765)	(1,412)	(16,198)
Less: Healthpeak’s share of unconsolidated joint venture NOI											(25,990)	(23,611)	(26,744)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI											25,581	25,497	24,482
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures											507,130	128,367	217,683
Income tax benefit (expense)											4,425	3,261	9,423
Equity income (loss) from unconsolidated joint ventures											1,985	6,100	(66,599)
Income (loss) from continuing operations			9,929	359,284	69,301	75,026	28,943	61,305	168,065	(120,585)	513,540	137,728	160,507
Income (loss) from discontinued operations			873	(1,298)	2,992	317	3,633	601	113,960	270,008	2,884	388,202	267,746
Net income (loss)			$ 10,802	$ 357,986	72,293	$ 75,343	$ 32,576	$ 61,906	$ 282,025	$ 149,423	516,424	525,930	428,253
Tax benefit recognized in conjunction with internal restructuring activities													51,000
Valuation allowance on deferred assets no longer realized													33,000
Tax benefit recognized from CARES Act													3,700
Corporate Non-segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues											0	0	0
Government grant income											0	0	0
Less: Interest income											0	0	0
Healthpeak’s share of unconsolidated joint venture total revenues											0	0	0
Healthpeak’s share of unconsolidated joint venture government grant income											0	0	0
Noncontrolling interests’ share of consolidated joint venture total revenues											0	0	0
Operating expenses											0	0	0
Healthpeak’s share of unconsolidated joint venture operating expenses											0	0	0
Noncontrolling interests’ share of consolidated joint venture operating expenses											0	0	0
Adjustments to NOI											0	0	0
Adjusted NOI											0	0	0
Plus: Adjustments to NOI											0	0	0
Interest income											0	0	0
Interest expense											(158,535)	(147,210)	(210,475)
Depreciation and amortization											0	0	0
General and administrative											(131,033)	(98,303)	(93,237)
Transaction costs											(2,486)	0	0
Impairments and loan loss reserves, net											0	0	0
Gain (loss) on sales of real estate, net											0	0	0
Gain (loss) on debt extinguishments												(225,824)	(42,912)
Other income (expense), net											3,013	6,309	5,133
Less: Government grant income											0	0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI											0	0	0
Plus: Noncontrolling interests’ share of consolidated joint venture NOI											0	0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures											(289,041)	(465,028)	(341,491)
Income tax benefit (expense)											4,425	3,261	9,423
Equity income (loss) from unconsolidated joint ventures											0	0	0
Income (loss) from continuing operations											(284,616)	(461,767)	(332,068)
Income (loss) from discontinued operations											2,884	388,202	267,746
Net income (loss)											(281,732)	(73,565)	(64,322)
Life Science
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net		$ 4,000
Life Science \| Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues											817,573	715,844	569,296
Government grant income											0	0	0
Less: Interest income											0	0	0
Healthpeak’s share of unconsolidated joint venture total revenues											9,921	5,757	448
Healthpeak’s share of unconsolidated joint venture government grant income											0	0	0
Noncontrolling interests’ share of consolidated joint venture total revenues											(268)	(292)	(239)
Operating expenses											(209,143)	(169,044)	(138,005)
Healthpeak’s share of unconsolidated joint venture operating expenses											(2,883)	(1,836)	(137)
Noncontrolling interests’ share of consolidated joint venture operating expenses											87	87	72
Adjustments to NOI											(62,754)	(46,589)	(20,133)
Adjusted NOI											552,533	503,927	411,302
Plus: Adjustments to NOI											62,754	46,589	20,133
Interest income											0	0	0
Interest expense											0	(232)	(234)
Depreciation and amortization											(302,649)	(303,196)	(217,921)
General and administrative											0	0	0
Transaction costs											(387)	(24)	(236)
Impairments and loan loss reserves, net											0	0	(14,671)
Gain (loss) on sales of real estate, net											3,744	0	0
Gain (loss) on debt extinguishments												0	0
Other income (expense), net											311,939	55	0
Less: Government grant income											0	0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI											(7,038)	(3,921)	(311)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI											181	205	167
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures											621,077	243,403	198,229
Income tax benefit (expense)											0	0	0
Equity income (loss) from unconsolidated joint ventures											(972)	1,118	(40)
Income (loss) from continuing operations											620,105	244,521	198,189
Income (loss) from discontinued operations											0	0	0
Net income (loss)											620,105	244,521	198,189
Medical Office
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net	$ 1,000				$ 10,000
Medical Office \| Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues											725,370	671,242	622,398
Government grant income											0	0	0
Less: Interest income											0	0	0
Healthpeak’s share of unconsolidated joint venture total revenues											2,999	2,882	2,772
Healthpeak’s share of unconsolidated joint venture government grant income											0	0	0
Noncontrolling interests’ share of consolidated joint venture total revenues											(35,717)	(35,363)	(34,597)
Operating expenses											(253,309)	(223,383)	(204,008)
Healthpeak’s share of unconsolidated joint venture operating expenses											(1,178)	(1,174)	(1,129)
Noncontrolling interests’ share of consolidated joint venture operating expenses											10,317	10,071	10,282
Adjustments to NOI											(15,513)	(11,118)	(5,544)
Adjusted NOI											432,969	413,157	390,174
Plus: Adjustments to NOI											15,513	11,118	5,544
Interest income											0	0	0
Interest expense											(6,900)	(2,837)	(400)
Depreciation and amortization											(279,546)	(255,746)	(222,165)
General and administrative											0	0	0
Transaction costs											(1,255)	(323)	0
Impairments and loan loss reserves, net											0	(21,577)	(10,208)
Gain (loss) on sales of real estate, net											10,659	190,590	90,390
Gain (loss) on debt extinguishments												0	0
Other income (expense), net											12,709	(2,725)	0
Less: Government grant income											0	0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI											(1,821)	(1,708)	(1,643)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI											25,400	25,292	24,315
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures											207,728	355,241	276,007
Income tax benefit (expense)											0	0	0
Equity income (loss) from unconsolidated joint ventures											852	794	798
Income (loss) from continuing operations											208,580	356,035	276,805
Income (loss) from discontinued operations											0	0	0
Net income (loss)											208,580	356,035	276,805
CCRC \| Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues											494,935	471,325	436,494
Government grant income											6,765	1,412	16,198
Less: Interest income											0	0	0
Healthpeak’s share of unconsolidated joint venture total revenues											0	6,903	35,392
Healthpeak’s share of unconsolidated joint venture government grant income											380	200	920
Noncontrolling interests’ share of consolidated joint venture total revenues											0	0	0
Operating expenses											(400,539)	(380,865)	(440,528)
Healthpeak’s share of unconsolidated joint venture operating expenses											0	(6,639)	(32,125)
Noncontrolling interests’ share of consolidated joint venture operating expenses											0	0	0
Adjustments to NOI											2,300	3,241	97,072
Adjusted NOI											103,841	95,577	113,423
Plus: Adjustments to NOI											(2,300)	(3,241)	(97,072)
Interest income											0	0	0
Interest expense											(7,509)	(7,701)	(7,227)
Depreciation and amortization											(128,374)	(125,344)	(113,851)
General and administrative											0	0	0
Transaction costs											(725)	(1,445)	(17,994)
Impairments and loan loss reserves, net											0	0	0
Gain (loss) on sales of real estate, net											0	0	0
Gain (loss) on debt extinguishments												0	0
Other income (expense), net											(1,380)	2,141	187,844
Less: Government grant income											(6,765)	(1,412)	(16,198)
Less: Healthpeak’s share of unconsolidated joint venture NOI											(380)	(464)	(4,187)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI											0	0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures											(43,592)	(41,889)	44,738
Income tax benefit (expense)											0	0	0
Equity income (loss) from unconsolidated joint ventures											539	1,484	(1,547)
Income (loss) from continuing operations											(43,053)	(40,405)	43,191
Income (loss) from discontinued operations											0	0	0
Net income (loss)											(43,053)	(40,405)	43,191
Other Non-Reporting Segment \| Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues											23,300	37,773	16,687
Government grant income											0	0	0
Less: Interest income											(23,300)	(37,773)	(16,553)
Healthpeak’s share of unconsolidated joint venture total revenues											73,885	67,835	74,023
Healthpeak’s share of unconsolidated joint venture government grant income											498	1,549	359
Noncontrolling interests’ share of consolidated joint venture total revenues											0	0	0
Operating expenses											0	13	0
Healthpeak’s share of unconsolidated joint venture operating expenses											(57,632)	(51,866)	(53,779)
Noncontrolling interests’ share of consolidated joint venture operating expenses											0	0	0
Adjustments to NOI											169	(47)	433
Adjusted NOI											16,920	17,484	21,170
Plus: Adjustments to NOI											(169)	47	(433)
Interest income											23,300	37,773	16,553
Interest expense											0	0	0
Depreciation and amortization											0	0	(12)
General and administrative											0	0	0
Transaction costs											0	(49)	(112)
Impairments and loan loss reserves, net											(7,004)	(1,583)	(18,030)
Gain (loss) on sales of real estate, net											(5,325)	0	(40)
Gain (loss) on debt extinguishments												0	0
Other income (expense), net											(13)	486	41,707
Less: Government grant income											0	0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI											(16,751)	(17,518)	(20,603)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI											0	0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures											10,958	36,640	40,200
Income tax benefit (expense)											0	0	0
Equity income (loss) from unconsolidated joint ventures											1,566	2,704	(65,810)
Income (loss) from continuing operations											12,524	39,344	(25,610)
Income (loss) from discontinued operations											0	0	0
Net income (loss)											$ 12,524	$ 39,344	$ (25,610)